Pompholyx Clinical Trial
Official title:
Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema
| NCT number | NCT00442091 |
| Other study ID # | 20070010 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | December 2010 |
| Est. completion date | December 2019 |
| Verified date | March 2020 |
| Source | Odense University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Dandelion juice has been used in herbal medicine for at least 1000 years. Vesicular hand eczema is a rare, but difficult to treat, type of hand eczema. One case report has shown that ingestion of dandelion juice could induce a beneficial effect on this type of eczema. The purpose of this study is to test whether this effect can be retrieved in other patients.
| Status | Completed |
| Enrollment | 4 |
| Est. completion date | December 2019 |
| Est. primary completion date | December 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Adult patients with dyshidrotic eczema for at least 1 year and negative patch test reactions to Compositae (tested within the last 3 years) and normal renal and hepatic blood tests. Exclusion Criteria: - Treatment with systemic steroids or other immunosuppressive/-modulating drugs, including UV therapy, within the last 3 months. - Pregnancy, lactation. - Compositae contact allergy. - Liver or gall bladder disease. - Abnormal renal or hepatic blood tests. |
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Department of Dermatology, Odense University Hospital | Odense |
| Lead Sponsor | Collaborator |
|---|---|
| Odense University Hospital |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Improvement in dyshidrotic hand eczema in the study period assessed by HECSI score. | 3-4 weeks | ||
| Secondary | Improvement in dyshidrotic eczema in the study period assessed by the patient (Visual Analog Scale). | 3-4 weeks |